Goelzer Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Goelzer Investment Management, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $590.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$590.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 540,417 | $497.1M |
| MRKMerck & Co., Inc. | 127,005 | $15.3M |
| ABBVAbbVie Inc. | 65,122 | $14.2M |
| JNJJOHNSON & JOHNSON | 56,794 | $13.9M |
| BMYBRISTOL MYERS SQUIBB CO | 156,664 | $9.5M |
| MCKMcKesson Corporation | 10,111 | $8.7M |
| AZNASTRAZENECA PLC | 41,673 | $8.2M |
| PFEPFIZER INC | 181,055 | $5.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 18,545 | $5.0M |
| MBXMBX Biosciences, Inc. | 164,172 | $4.9M |
| CAHCardinal Health Inc. | 9,094 | $1.9M |
| IQVIQVIA Holdings Inc. | 11,266 | $1.9M |
| ELVElevance Health Inc. | 5,267 | $1.5M |
| ABTABBOTT LABORATORIES | 9,653 | $991K |
| ZTSZoetis Inc. | 6,296 | $744K |
| PMPhilip Morris International Inc | 3,133 | $518K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 947 | $423K |
| AMGNAMGEN INC | 824 | $290K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.